Trial intelligence / Profile preview

Qigui Tongfeng Tablet in Chronic Gout (Phase II)

CTR20160413Phase 2Active

Sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd.
Start
Mar 2018
Countries
1
01

Overview

A Phase 2 trial of qigui tongfeng in gout, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Mar 2018; status: active.

02

Drugs

qigui tongfeng
03

Conditions

gout

Beyond the preview

Go deeper on CTR20160413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call